Engaged Capital LLC Has $112.82 Million Stock Position in Evolent Health, Inc. (NYSE:EVH)

Engaged Capital LLC lessened its position in shares of Evolent Health, Inc. (NYSE:EVH) by 3.0% in the third quarter, HoldingsChannel reports. The fund owned 3,989,468 shares of the technology company’s stock after selling 121,990 shares during the period. Evolent Health accounts for approximately 18.3% of Engaged Capital LLC’s investment portfolio, making the stock its largest holding. Engaged Capital LLC’s holdings in Evolent Health were worth $112,822,000 as of its most recent SEC filing.

A number of other institutional investors also recently made changes to their positions in the company. CANADA LIFE ASSURANCE Co boosted its stake in shares of Evolent Health by 8.4% in the first quarter. CANADA LIFE ASSURANCE Co now owns 39,522 shares of the technology company’s stock valued at $1,297,000 after buying an additional 3,064 shares during the period. Price T Rowe Associates Inc. MD boosted its stake in shares of Evolent Health by 11.7% in the first quarter. Price T Rowe Associates Inc. MD now owns 717,334 shares of the technology company’s stock valued at $23,522,000 after buying an additional 75,376 shares during the period. Moody National Bank Trust Division boosted its stake in shares of Evolent Health by 30.8% in the second quarter. Moody National Bank Trust Division now owns 112,770 shares of the technology company’s stock valued at $2,156,000 after buying an additional 26,548 shares during the period. Harbor Capital Advisors Inc. boosted its stake in shares of Evolent Health by 393.6% in the second quarter. Harbor Capital Advisors Inc. now owns 176,021 shares of the technology company’s stock valued at $3,366,000 after buying an additional 140,357 shares during the period. Finally, Valeo Financial Advisors LLC bought a new stake in shares of Evolent Health in the second quarter valued at approximately $2,705,000.

Evolent Health Trading Down 2.5 %

Shares of EVH opened at $12.93 on Friday. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.58. The firm’s fifty day simple moving average is $22.19 and its two-hundred day simple moving average is $23.49. Evolent Health, Inc. has a 12 month low of $11.17 and a 12 month high of $35.00.

Analyst Ratings Changes

Several equities research analysts recently issued reports on the company. Truist Financial reiterated a “buy” rating and issued a $33.00 price target on shares of Evolent Health in a research note on Tuesday, August 27th. JMP Securities lowered their price objective on shares of Evolent Health from $34.00 to $31.00 and set a “market outperform” rating for the company in a research report on Friday, August 9th. Oppenheimer lowered their price objective on shares of Evolent Health from $34.00 to $28.00 and set an “outperform” rating for the company in a research report on Monday, November 18th. KeyCorp started coverage on shares of Evolent Health in a research report on Friday, October 11th. They set an “overweight” rating and a $35.00 price objective for the company. Finally, Stephens downgraded shares of Evolent Health from an “overweight” rating to an “equal weight” rating and lowered their price objective for the company from $38.00 to $16.00 in a research report on Friday, November 8th. One analyst has rated the stock with a hold rating, nine have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, Evolent Health presently has a consensus rating of “Buy” and a consensus price target of $25.90.

Evolent Health Profile

Evolent Health, Inc, through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.